Suppliers / Zhuhai United Laboratories

Zhuhai United Laboratories

China Updated 9 July 2026

Zhuhai United Laboratories is an API manufacturer based in China. It holds one active US drug master file and 11 valid CEPs across a filed portfolio of 12 molecules. Its filings concentrate with MINSA (CR), ARCSA (EC) and TMDA (TZ). Its GMP standing is certified by EMA, MFDS (Korea) and ANVISA (Brazil). Its most recent recorded inspection, by US FDA, closed on 3 August 2023 as OAI.

1
active US DMFs
11
valid CEPs
4
registered plants 1 with an FDA FEI number
3
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 3 August 2023 OAI US FDA
  • 16 July 2019 OAI US FDA
  • 15 September 2017 OAI US FDA
  • 31 March 2015 OAI US FDA
  • 23 October 2012 NAI US FDA
  • 3 September 2009 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
ZHUHAI - TAIWAN, China Not on file
Sanzao Town, China Not on file
Zhuhai, China Not on file
China, China 3006531950

What they file, and where

Molecule Regulators Docs
Potassium Clavulanate EDQM 4
Amoxicillin SFDA (Saudi Arabia) 2
Amoxicillin Sodium EDQM 2
Amoxicillin Trihydrate EDQM 2
Ampicillin SFDA (Saudi Arabia), US FDA 2
Sulbactam EDQM, SFDA (Saudi Arabia) 2
Ampicillin Sodium EDQM 1
Ampicillin Trihydrate Compacted EDQM 1
Cefoperazone SFDA (Saudi Arabia) 1
Cefotaxime SFDA (Saudi Arabia) 1
Show all 12 molecules on file
Ceftriaxone SFDA (Saudi Arabia) 1
Meropenem SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 1 None
ARCSA (EC) 1 None
TMDA (TZ) 1 None
EMA None 3
MFDS (Korea) None 2
ANVISA (Brazil) None 1

Comparing suppliers?

Choose your molecules and target markets. Zhuhai United Laboratories comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was OAI, on 3 August 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates